课题基金 / 基金详情

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
COVID 补充材料 - 流感疫苗创新中心 (CIVICS) 项目的 A 部分,用于设计和评估创新型流感疫苗方法,
批准号:
10285380
负责人:
TED ROSS
金额:
$96.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2021-08-19

项目摘要

项目成果

TED ROSS的其他基金

相似基金

相关文献

中文摘要
翻译
该合同计划的目标是支持提高季节性流感疫苗、SARS-COV-2疫苗的免疫原性和持久性,并支持开发创新的流感疫苗方法,提供强大、持久、广泛保护的粘膜和系统抗流感免疫(“通用流感疫苗”)。
英文摘要
The objective of this contract program is to support improvements in the immunogenicity and durability of seasonal influenza vaccines, SARS-COV-2 vaccines and the development of innovative influenza vaccine approaches that provide robust, durable, broadly protective mucosal and systemic anti-influenza immunity (“universal influenza vaccines”).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10242598
  • 项目类别:
  • 资助金额:
    $1074.98万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10021763
  • 项目类别:
  • 资助金额:
    $800.0万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10788197
  • 项目类别:
  • 资助金额:
    $1070.0万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10621131
  • 项目类别:
  • 资助金额:
    $1018.84万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
海外基金